ENSC - Ensysce Biosciences, Inc.

QQQ $ 602.34 $ -5.20 (-0.85 %)

DIA $ 466.18 $ -5.48 (-1.16 %)

SPY $ 664.83 $ -6.26 (-0.93 %)

TLT $ 89.11 $ 0.22 (0.25 %)

GLD $ 370.86 $ -4.31 (-1.15 %)

Previous Close

$ 1.96

Open

$ 2.01

Bid

$ 1.96 x 389

Ask

$ 2.01 x 300

Day's Range

$ 1.96 - $ 2.07

52 Week Range

$ 1.62 - $ 11.13

Volume

195,334

Average Volume

Market Cap

6.94M

Beta (5Y Monthly)

$ 2.37

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-14-2025	09-30-2025	10-Q
2	08-13-2025	06-30-2025	10-Q
3	05-13-2025	03-31-2025	10-Q
4	03-10-2025	12-31-2024	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-14-2024	06-30-2024	10-Q
7	05-10-2024	03-31-2024	10-Q
8	03-14-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-10-2023	06-30-2023	10-Q
11	05-15-2023	03-31-2023	10-Q
12	03-30-2023	12-31-2022	10-K
13	11-14-2022	09-30-2022	10-Q
14	08-11-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	03-31-2022	12-31-2021	10-K
17	11-15-2021	09-30-2021	10-Q
18	08-16-2021	06-30-2021	10-Q
19	06-08-2021	03-31-2021	10-Q
20	03-15-2021	12-31-2020	10-K
21	11-09-2020	09-30-2020	10-Q
22	08-07-2020	06-30-2020	10-Q
23	05-07-2020	03-31-2020	10-Q
24	03-10-2020	12-31-2019	10-K
25	11-07-2019	09-30-2019	10-Q
26	08-07-2019	06-30-2019	10-Q
27	05-07-2019	03-31-2019	10-Q
28	03-11-2019	12-31-2018	10-K
29	11-07-2018	09-30-2018	10-Q
30	08-01-2018	06-30-2018	10-Q
31	05-03-2018	03-31-2018	10-Q
32	03-09-2018	12-31-2017	10-K
33	01-09-2018	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Watching Ensysce Biosciences; Zacks Small-...
11/17/2025 16:07:06

https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_ENSC_Sorensen.pdf

Ensysce Biosciences Secures $4M Financing ...
11/17/2025 13:16:09

~Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~SA...

Ensysce Biosciences Q3 EPS $(1.29) Misses ...
11/14/2025 21:18:41

Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(1.29) per share which missed the analyst consensus estimate of...

12 Health Care Stocks Moving In Monday's P...
10/13/2025 12:08:59

Ensysce Biosciences Showcases TAAP and MPA...
10/10/2025 12:17:31

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company p...

Ensysce Biosciences Q2 EPS $(0.79) Beats $...
08/13/2025 20:20:52

Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $...

12 Health Care Stocks Moving In Thursday's...
07/31/2025 12:08:18

Ensysce Biosciences Receives FDA Feedback ...
07/31/2025 12:05:48

12 Health Care Stocks Moving In Wednesday'...
07/23/2025 12:08:15

Watching Ensysce Biosciences; Zacks Small-...
07/16/2025 15:06:39

https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_07162025_ENSC_Sorensen.pdf

Ensysce Biosciences Launches Phase 3 Trial...
07/16/2025 12:05:22

~ FDA Protocol Review Completed ~~ Rho, Inc. Selected as Clinical Research Partner ~SAN DIEGO, CA / ACCESS Newswire / July 16, ...

Ensysce Biosciences Says It Fully Enrolled...
06/24/2025 12:11:46

~ Treatment to Evaluate Effect of Food on Overdose Protection of MPAR ~~ Grant Funds from NIDA Accelerating Clinical Developmen...

Ensysce Biosciences Secures $5.3M In Conti...
06/04/2025 12:13:08

~ PF614-MPAR Moving to Next Stage of Development, Finalizing Drug Formulation ~~ Funds Accelerate Path Towards Commercialization ~

12 Health Care Stocks Moving In Friday's A...
05/16/2025 21:05:51

Watching Ensysce Biosciences; Zacks Small-...
05/14/2025 15:04:22

https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05142025_ENSC_Sorensen.pdf

Ensysce Biosciences Q1 EPS $(1.39) Beats $...
05/13/2025 20:39:17

Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(1.39) per share which beat the analyst consensus estimate of $...

12 Health Care Stocks Moving In Thursday's...
04/24/2025 17:05:54

12 Health Care Stocks Moving In Thursday's...
04/24/2025 12:06:59

why-servicenow-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket

Why ServiceNow Shares Are Trading Higher B...
04/24/2025 09:30:36

ensysce-biosciences-stock-doubles-in-one-trading-session---heres-why

Ensysce Biosciences Stock Doubles In One T...
04/23/2025 21:11:43

Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protectio...